Global Market Research Report on Parkinsons disease Drug Market 2017 is a professional and in-depth complete study on the current state of the Parkinsons disease Drug worldwide.

Deerfield Beach, FL -- (SBWire) -- 04/21/2017 --Latest industry research report on Parkinson's disease Market. Parkinson's disease is a progressive, degenerative neurological motor disorder, primarily affecting the dopaminergic cells of the brain. The symptoms of this disease include rigidity, tremor, bradykinesia and postural instability.

The global Parkinson's disease drug market has witnessed remarkable growth in recent years owing to a large patient pool and increased diagnosis rates. According to the Parkinson's Disease Foundation, there are about 10 million people suffering from Parkinson's disease globally. Parkinson's, in terms of its presence, has a higher frequency in the developed countries. In the United States (U.S.), around 60,000 new cases are diagnosed with Parkinson's, each year. Parkinson's disease is an idiopathic disease occurring due to unknown causes.

Get Free Sample Report Of Parkinson's disease Market @ http://www.marketresearchstore.com/report/world-parkinsons-disease-drug-market-opportunities-and-71680#RequestSample

Presently, only symptomatic drug treatments are available in the market. Moreover, these symptoms are diagnosed at later stages when most of the dopamine producing cells have lost their function. This scenario indicates an impending need for innovative drugs.

Rising old age population and higher incidences of neurodegenerative diseases are two significant factors that drive the growth of this market. Moreover, increasing R&D investment and number of drugs in the pipeline are further expected to fuel the market growth. However, high cost of treatment and lack of expertise for early diagnosis is likely to curtail the market growth.

For instance, in Jan 2015, Neuropore Therapies Inc. and UCB S.A, a Belgian drug maker entered into commercialization agreement for NPT200-11, a small molecule drug useful in debilitating the Parkinson's disease.

Do Inquiry To Buy Report Of Parkinson's disease Market @ http://www.marketresearchstore.com/report/world-parkinsons-disease-drug-market-opportunities-and-71680#InquiryForBuying

The global Parkinson's disease market is segmented below:

Parkinson's Disease Market By Drug Type

Marketed Drugs
Levodopa
Dopamine agonists
Apomorphine
Glutamate antagonist
Anticholinergics
COMT inhibitors
MAO-B inhibitors
Pipeline Drugs

Parkinson's Disease Market By Geography

North America
Europe
Asia-Pacific
LAMEA

About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/